In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

Transcatheter left atrial appendage occlusion is an increasingly used alternative to oral
anticoagulation in selected patients with atrial fibrillation. Pre-procedural imaging is a …

This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …

Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial
fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of …

Aims To evaluate the safety and efficacy of left atrial appendage occlusion (LAAO) with the
Amplatzer™ Amulet™ occluder. Methods and results Patients with atrial fibrillation eligible …

Objectives This study sought to investigate clinical outcomes associated with left atrial
appendage occlusion (LAAO) versus direct oral anticoagulants (DOACs) in patients with …

Contemporary evidence supports device-based transcatheter interventions for the
management of patients with structural heart disease. These procedures, which include …

Intracardiac echocardiography has historically been used to guide a limited number of
transcatheter cardiac interventions. However, the tremendous advances in structural heart …

Objectives: The aim of this study is to review the evidence on the use of antithrombotic
therapy and risk of device-related thrombosis after left atrial appendage closure …

Objectives This study sought to report early experience with the new-generation Watchman
FLX device (Boston Scientific, Marlborough, Massachusetts). Background The new …